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Abstract
Background: The increased resistance of microorganisms to the currently used antimicrobials has lead to the
evaluation of other agents that might have antimicrobial activity. Medicinal plants are sources of phytochemicals
which are able to initiate different biological activities including antimicrobials
Materials and methods: In vitro antibacterial (MIC, MBC and time-kill studies) of polyphenol-rich fractions from
Sida alba L. (Malvaceae) was assessed using ten bacteria strains (Gram-negative and Gram-positive).
Results: All test bacteria were susceptible to the polyphenol-rich fractions. Time-kill results showed that after 5 h
exposition there was no viable microorganism in the initial inoculum and the effect of polyphenol-rich fractions
was faster on Enterococcus faecalis (Gram-positive bacterium) comparatively to the other bacteria strains.
Conclusion: The data analysis indicates that the tested of polyphenol-rich fractions has significant effects when
compared with the standard antibiotic. These results therefore justify the traditional use of sida alba L., alone or in
combination with other herbs to treat bacterial infections.
Background
The use of medicinal herbs in traditional system of
medicine is a common practice in many cultures around
the world especially in African societies. This practice
has gained widespread acceptance in developing as well
as in developed nations. Researchers are also beginning
to appreciate the role of medicinal plants in health care
delivery [1]. In recent time, interest with herbal medi-
cine for antimicrobial activities has been increased sig-
n i f i c a n t l y .T h i si sa sar e s u l to ft h ee f f e c t i v e n e s s ,l o w
cost and the availability of these herbal medicines, the
economic crisis, high cost of industrialized medicines,
inefficient public access to medical and pharmaceutical
care, in addition to the side effects caused by synthetic
drugs are some of the factors contributing to the central
role of medicinal plants in health care [2,3].
So, there is serious need to develop new antimicrobial
agents that are very effective with minimal unwanted
side effects and higher plants represent a potential
source of novel antibiotic prototypes [4]. Medical plants
have shown a promising alternative for the treatment of
infectious diseases. In the antibacterial research, the vast
majority, 78% of the new chemical entities are natural
or natural products derived molecules [5].
In effect, at last 35,000 plant species are used for medic-
inal purposes throughout the world [6]. The most impor-
tant industrial medicines nowadays are based on about 90
species of herbs and in developing countries, traditional
remedies are usually based on mixtures of herbs collected
from nature [7]. Among such plants, Sida alba L. (Malva-
ceae), is a herbaceous plant broadly distributed in tropical
and subtropical areas. The medicaments are prepared
most often from a combination of two or more plant pro-
ducts, which many a time many contain active constitu-
ents with multiple physiological activities and could be
used in treating various disease conditions [7]. In Burkina
Faso, the aqueous extracts of Sida alba L. (Malvaceae) are
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any medium, provided the original work is properly cited.mostly used in popular folk medicine for the treatment of
several diseases, particularly in the hepatitis virus diseases
[8]. Ethnobotanical investigations in the central region of
Burkina Faso and certain recent studies performed in
laboratory have shown that Sida alba L. is frequently and
widely used in traditional medicine to treat various kinds
of diseases such as infectious diseases in children, malaria,
fever, pain, variola, antibacterial, anti-inflammatory,
analgesic activities and hepatoprotective [8,9]. Previous
studies performed in our laboratory showed that aqueous
acetone extract of Sida alba L. contains saponosides, cou-
marins, steroids, polyphenol compounds and alkaloids and
possess antioxidant and ant-inflammatory properties [10].
Because pharmacological properties of Sida alba L. are
highly attractive to assess for a new drug discovery, the
present investigation reports the antimicrobial activities of
polyphenol-rich fractions from Sida alba L. The bacterio-
static, bactericidal and time-kill assay studies of polyphe-
nol-rich fractions were screened against clinical strains of
bacteria. The aim was to justify the traditional antimicro-
bial use of this species and to produce scientific data for a
future project for manufacturing phytomedicines, for use
in combination with conventional antimicrobial drugs to
better manage resistant bacteria infectious diseases.
Materials
Plants material
Sida alba L. was collected fresh in August 2008 in
Gampela, 25 Km east of Ouagadougou, capital of Bur-
kina Faso. The plant was botanically identified by Prof.
Millogo-Rasolodimby from the plants Biology Depart-
ment of the University of Ouagadougou. Voucher speci-
men (ID-10473) was deposited at the Herbarium of the
“Laboratoire de Biologie et d’Ecologie Végétale, UFR/
SVT of University of Ouagadougou”.
Bacterial strains and antibiotics
Microorganisms used in this study were isolated from
clinical samples at Laboratory of the General Hospital of
Ouagadougou in Burkina Faso. Commercially available
antibiotic diffusion discs (10 μg/disc) and Co-trimoxazol
were purchased from Alkom Laboratories LTD. Clinical
isolates were: Shigella dysenteriae, Shigella boydii, Shi-
gella flexneri, Salmonella thyphi, Klebsiella pneumonia,
Klebsiella arogenes, Escherichia coli, Enterococcus faeca-
lis, Enterobacter aeruginosa and Proteus mirabilis.T h e
following microorganisms were all identified by the use
of their biochemical profiles as recommended by the
manual “Bactériologie Medical” [11].
Chemicals
All reagents were of analytical grade. Acetone, n-hexane
were supplied by Fluka chemie (Buchs, Switzerland).
INT (p-iodonitrotetrazolium chloride) was purchased
from sigma-Aldrich chemie (Steinheim, Germany).
Methods
Polyphenols extraction
The harvested plant materials fresh (broken into leaf
stems) were dried in the laboratory at room temperature
(20-25°C), afterwards samples were ground to pass a
sieve of 0.3 mm. Polyphenols were extracted with aqu-
eous acetone (80%, v/v). The extract was then washed
with hexane to remove chlorophyll and other low mole-
cular weight compounds. Acetone was evaporated and
the extract was lyophilized and stored at 22°C prior to
biological tests. For the tests, lyophilized sample was dis-
solved with 10% DMSO in water at the desired concen-
tration [9].
In vitro antibacterial activity
Preparation of inocula
The susceptibility tests were performed by Mueller Hin-
ton agar-well diffusion method [12]. The bacterial
strains grown on nutrient agar at 37°C for 18 h were
suspended in a saline solution (0.9%, w/v)NaCl and
adjusted to a turbidity of 0.5 Mac Farland standard (10
8
CFU/ml). To obtain the inocula, these suspensions were
diluted 100 times in Muller Hinton broth to give 10
6
colony forming units (CFU)/ml [13].
Preparation of discs The stock solutions of polyphenols
from Sida alba L. was dissolved in 10% dimethylsulfox-
ide (DMSO) in water [14] at a final concentration of
100 μg/ml after a serial two-fold dilution. Each stock
solution of polyphenol-rich fractions from Sida alba L.
was sterilized by filtration through 0.22 μm sterilizing
Millipore express filter. The sterile discs (6 mm) were
impregnated with 10 μL of the sterile polyphenol-rich
fractions. Negative controls were prepared using discs
impregnated with 10% DMSO in water and commer-
cially available antibiotic diffusion discs (Co-trimoxazol
from Alkom Laboratories LTD) were used as positive
reference standards (10 μg/disc) for all bacterial strains.
Disc-diffusion assay Petri plates (9 cm) were prepared
with 20 ml of a base layer of molten Mueller Hinton
agar (DIFCO, Becton Dickinson, USA). Each Petri plate
was inoculated with 15 μl of each bacterial suspension
(10
6 CFU/ml). After drying in a sterile hood, 6 mm dia-
meter discs soaked with 10 μl of the different polyphe-
nol-rich fractions dilutions were placed on the agar.
Discs containing Co-trimoxazol were used as positive
controls and 10% DMSO was used as a negative control.
The plates were incubated for 24 h at 37°C and at 44°C
for Escherichia coli because this bacterium is thermo
resistant. The diameters of the inhibition zones were
evaluated in millimeters. The extract inducing inhibition
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terial. All tests were performed in triplicate and the bac-
terial activity was expressed as the mean of inhibition
diameters (mm) produced [15].
Micro-well dilution assay Minimum inhibitory concen-
tration (MIC) was determined by the microdilution
method in culture broth as recommended by [16]. Eight
serial two-fold dilutions of polyphenol-rich fractions or
conventional antibiotic were prepared as described
before, to obtain final concentration range of 400 to
3.125 μg/ml. The 96-well micro-plates (NUNC, Dane-
mark) containing 100 μL of Mueller Hinton (MH) broth
were used. For each bacteria strain, three columns of
eight wells to the micro-plate were used. Each well has
getting: the culture medium + polyphenol-rich fractions
or the combination of polyphenol-rich fractions with
Co-trimoxazol + inoculum (10 μl of inocula) and INT
(50 μl; 0.2 mg/ml). The plates were covered and incu-
bated at 37°C and at 44°C for Escherichia coli for 24 h.
All tests were performed in triplicate and the bacterial
activity was expressed as the mean of inhibitions pro-
duced. Inhibition of bacterial growth was judged by rose
or yellow colour. The MIC was defined as the lowest
concentration of extract or fraction of extract at which
no colony was observed after incubation. So, the MIC
was defined as the lowest concentration at which no
visible growth was observed.
Minimal bactericidal concentration (MBC) Minimum
bactericidal concentration (MBC) was recorded as a
lowest extract concentration killing 99.9% of the bacter-
ial inocula after 24 h incubation at 37°C. Each experi-
ment was repeated at least three times. MBC values
were determined by removing 100 μlo fb a c t e r i a ls u s -
pension from subculture demonstrating no visible
growth and inoculating nutrient agar plates. Plates were
incubated at 37°C for a total period of 24 h. The MBC
is determined with the wells whose the concentrations
are ≥ MIC [15,17]. The MBC were determined in Muel-
ler Hinton (MH) agar (DIFCO, Becton Dickinson, USA)
medium.
Evaluation of bactericidal and bacteriostatic capacity
The action of an antibacterial on the bacterial strains
can be characterized with two parameters such as Mini-
mum inhibitory concentration (MIC) and Minimum
bactericidal concentration (MBC). According to the
ratio MBC/MIC, we appreciated antibacterial activity. If
the ratio MBC/MIC = 1 or 2, the effect was considered
as bactericidal but if the ratio MBC/MIC = 4 or 16, the
effect was defined as bacteriostatic [18].
Time-kill assay A bactericidal effect is defined as a 3
Log decrease in the CFU/ml or a 99.9% kill over a speci-
fied time [19]. The definition of kill for this study has
been used as per [20]. Kill-time can be determined at 6
h [21]. A 90% kill at 6 h is equivalent to a 99.9% kill at
24 h [22]. In this study the kill measurement was deter-
mined by the actual reduction in viable counts at 6 h
for each isolate. Bacteria strains possessing the bacterici-
dal effect were chosen to perform time-kill assay. Thus,
0.5 Mac Farland standards suspensions of the microor-
ganisms were diluted to have 50 ml of approximately
10
6 CFU/ml in nutriment broth, and the concentration
corresponding to the best MIC, were respectively added
to the corresponding culture. The cultures were incu-
bated at 37°C. At 0, 1, 2, 3, 4, 5 and 6 h, an aliquot of
100 μl was removed and diluted with 10 ml sterile
broth. The obtained suspension was used to inoculate 9
cm diameter Petri plates with a sterile non toxic cotton
swab on a wooden applicator as indicated before in the
agar-well diffusion assay. After 24 h incubation at 37°C,
the viability of the microorganisms was evaluated by the
presence of colonies on the plates. The experiment was
carried out twice following [9] method with light
modifications.
Results
In this present study, ten bacteria strain (Gram-negative
and Gram-positive bacteria) were used. The antibacterial
assays were performed by the agar-well diffusion and
the broth micro dilution methods; so that they could be
qualified and quantified by inhibition zone diameters,
MIC, MBC, Time-kill assays. One noticed that the sus-
ceptibility of the bacteria tot h ep o l y p h e n o l - r i c hf r a c -
tions on the basis of inhibition zone diameters varied
according to the microorganism, the results are reported
in Table 1. There is a significant variation in the dia-
meters of inhibition zone values (DIZ) of polyphenol-
rich fractions (Table 1).
According to the results, the combination of ployphe-
nol-rich fractions with Co-trimoxazol has the high
Table 1 Inhibition zone diameters (mm) recorder in agar-
well diffusion assay using polyphenol-rich fractions from
Sida alba L. and Co-trimoxazol
Microorganisms Co-trimoxazol Polyphenol
Shigella dysenteria 19.00 ± 1.73 22.66 ± 0.58
Shigella boydii 20.66 ± 0.58 21.33 ± 4.04
Shigella flexneri 19.00 ± 1.00 23.66 ± 4.93
Salmonella thyphi nd 24.33 ± 1.15
Klebsiella pneumonia nd 29.66 ± 1.53
Klebsiella arogenes nd 14.00 ± 1.00
Escherichia coli nd 29.00 ± 1.00
Enterococcus faecalis 21.00 ± 1.00 28.66 ± 1.53
Enterobacter aeruginosa nd 22.00 ± 2.65
Proteus mirabilis 20.66 ± 1.53 24.66 ± 1.53
The results are the means of number of the colonies ± standard deviations.
nd: no detected activity.
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alone (Table 2).
As for the micro-well dilution assay (MIC) and Mini-
mum bactericidal concentration (MBC) of polyphenol-
rich fractions, result varied according to the microor-
ganism (Table 3). About the micro-well dilution assay
(MIC) and Minimum bactericidal concentration (MBC)
of the combination of polyphenol-rich fractions with
Co-trimoxazol, results were represented by (Table 4).
The MIC values were ranged from 12.5 to 50 μg/ml and
for the MBC values were ranged from 25 to 200 μg/ml.
The bactericidal and bacteriostatic effect of polyphenol-
rich fractions and the combination of polyphenol-rich
fractions with Co-trimoxazol was determined using the
ratio MBC/MIC (Table 3 and Table 4).
Concerning the time-kill assay of polyphenol-rich frac-
tions (Table 5) and the combination of polyphenol-rich
fractions with Co-trimoxazol (Table 6), the results
showed that after 5 h exposition there was no viable
microorganism in the initial inoculums. The effect of
polyphenol-rich fractions and the combination of poly-
phenol-rich fractions with Co-trimoxazol was faster on
Enterococcus faecalis than the other bacteria strains
(Table 5 and Table 6).
Discussion
Previous studies have been carried out in different parts
of the globe to extract plant products for screening anti-
bacterial activity [23]. Plants produce highly bioactive
molecules that allow them to interact with other organ-
isms in their environnement. Many of these substances
are important in the defense against herbivores and con-
tribute to the resistance to diseases [24]. Many investi-
gators have evaluated the bioactivity of plant extracts
and the isolated constituents against the serious infec-
tious organisms [25].
In Africa, for the treatment of several infections, indi-
genous medicinal plants are often the only means [26].
Infectious due to multidrug-resistant microorganisms,
pose an important clinical problem. Many of bacterial
strains are resistant to the standard antibiotic (Co-tri-
mozaxol) comparatively to the polyphenol-rich fractions.
One could say that, the metabolites have been shown to
be responsible for therapeutic activity of plants [27].
According to a recent study, aqueous acetone extract of
Sida alba L. contains saponosides, coumarins, steroids,
polyphenol compounds and alkaloids [10]. The natural
products were found to possess promising antimicrobial
activities when applied alone or in combination with
conventional antimicrobial drugs and the metabolites
have been shown to be responsible for therapeutic activ-
ity of plants [28]. This aspect is effectively checked by
our different results.
Table 2 Inhibition zone diameters (mm) recorder in agar-
well diffusion assay using the combination of
polyphenol-rich fractions with Co-trimoxazol
Microorganisms Polyphenol + Co-tri
Shigella dysenteria 27.66 ± 1.53
Shigella boydii 29.33 ± 0.58
Shigella flexneri 29.00 ± 1.73
Salmonella thyphi 12.33 ± 1.15
Klebsiella pneumonia 13.33 ± 2.31
Klebsiella arogenes 12.66 ± 3.79
Escherichia coli 12.33 ± 3.22
Enterococcus faecalis 29.66 ± 2.89
Enterobacter aeruginosa 14.66 ± 1.53
Proteus mirabilis 27.00 ± 1.00
The results are the means of number of the colonies ± standard deviations.
nd: no detected activity, Co-tri: Co-trimoxazol
Table 3 Bacteriostatic (-) and Bactericidal (+) effects of
Sida alba L. polyphenol-rich fractions
Microorganisms MIC (μg/ml) MBC(μg/ml) Effects
Shigella dysenteriae 50 ± 00 100 ± 0.00 +
Shigella boydii 50 ± 0.00 100 ± 0.00 +
Shigella flexneri 100 ± 0.00 200 ± 0.00 -
Salmonella thyphi 100 ± 0.00 400 ± 0.00 -
Klebsiella arogenes 100 ± 0.00 400 ± 0.00 -
Klebsiella pneumonia 50 ± 0.00 200 ± 0.00 -
Escherichia coli 50 ± 0.00 200 ± 0.00 -
Enterococcus faecalis 25 ± 0.00 50 ± 0.00 +
Enterobacter aeruginosa 25 ± 0.00 100 ± 0.00 -
Proteus mirabilis 25 ± 0.00 50 ± 0.00 +
The results are the means of number of the colonies ± standard deviations.
+: bactericidal effect, - bacteriostatic effect
Table 4 Bacteriostatic (-) and Bactericidal (+) effects of
combination of polyphenol-rich fractions with Co-
trimoxazol
Microorganisms MIC (μg/
ml)
MBC (μg/
ml)
MBC/
MIC
Effect
Shigella dysenteria 25 ± 0.00 50 ± 0.00 2 +
Shigella boydii 25 ± 0.00 50 ± 0.00 2 +
Shigella flexneri 25 ± 0.00 50 ± 0.00 2 +
Salmonella thyphi 25 ± 0.00 200 ± 0.00 4 -
Klebsiella pneumonia 100 ± 0.00 400 ± 0.00 4 -
Klebsiella arogenes 100 ± 0.00 400 ± 0.00 4 -
Escherichia coli 100 ± 0.00 400 ± 0.00 4 -
Enterococcus faecalis 12.5 ± 0.00 25 ± 0.00 2 +
Enterobacter
aeruginosa
100 ± 0.00 400 ± 0.00 4 -
Proteus mirabilis 12.5 ± 0.00 25 ± 0.00 2 +
The results are the means of number of the colonies ± standard deviations
+: bactericidal effect, -: bacteriostatic effect
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extract showed the significant results when compared
with the Co-trimoxazol. Indeed, the antibacterial activity
profile of the isolated constituents (polyphenols) when
compared with antibiotic effects shows that the activity
depends on the pure form of the constituents. This may
be due to the fact that the bioactive constituents such as
polyphenol compounds were responsible for the antimi-
crobial activity. In effect, some previous studies showed
that polyphenolic compounds cause inhibition of a wide
range of microorganisms. Phenol is well known as a
chemical antiseptic [29]. In addition, Phenolic and terpe-
nic antimicrobial activities are well documented [15].
Polyphenols, such as tannins and flavonoids, are impor-
tant antibacterial activity [26]. The antimicrobial activity
of flavonoids is due to their ability to complex with
extracellular and soluble protein and to complex with
bacterial cell wall while that of tannins may be related
to their ability to inactivate microbial adhesions,
enzymes and cell envelop proteins [24]. We noticed that
our extracts or in combination showed relatively the
best inhibitory activity against Enterococcus faecalis a
Gram-positive bacterium followed by Proteus mirabilis a
Gram-negative bacterium. The highest sensitivity of
Enterococcus faecalis may be due to its cell wall struc-
ture and outer membrane [30]. Gram-positive bacteria
are generally more sensitive in the extracts than Gram-
negative bacteria [31]. A possible explanation for these
observations may lie in the significant differences in the
outer layers of Gram-positive bacteria. The permeability
of the cell wall of the Gram-negative organism is gener-
ally less efficient than Gram-positive ones probably
because of the presence of the high level of phospholi-
pids in the cell wall compared with Gram-positive bac-
teria [32].
Gram-negative bacteria however, possess an outer
membrane and unique periplasme space not found in
Gram-positive bacteria [32]. The resistance of Gram-
negative bacteria towards antibacterial substances is
related to the hydrophilic surface of their outer mem-
brane which is rich in lipopolysaccharide molecules, pre-
senting a barrier to the penetration of numerous
antibiotic molecules and is also associated with the
enzymes in periplasme space, which are capable of
breaking down the molecules introduced from outside
[33]. The resistances of the bacteria to the current anti-
biotics necessitate the further studies on the isolated
constituents to find out their safety and efficacy profile.
This highlights the continuous interest in laboratory
screening of medicinal plants, not only to determine the
scientific rationale for their usage, but also to discover
new active principles. African medicinal plants have
been focused on phenolic compounds, terpenoids or
essential oils [34]. The plants have been found to exert
good in vitro antimicrobial activities and some active
principles have been isolated.
Table 6 Viability of microorganisms after 6 h exposure of the combination of polyphenol extracts with Co-trimoxazol
Microorganisms Time-kill (h)
0h 1h 2h 3h 4h 5h 6h
Shigella dysenteriae + (UC) + (UC) 23 ± 03 14 ± 01 05 ± 03 - -
Shigella boydii + (UC) + (UC) 25 ± 01 13 ± 01 04 ± 01 - -
Shigella flexneri + (UC) + (UC) 23 ± 03 14 ± 02 05 ± 01 - -
Enterococcus faecalis + (UC) + (UC) 21 ± 01 06 ± 01 - - -
Proteus mirabilis + (UC) + (UC) 26 ± 03 15 ± 01 07 ± 03 - -
The results are the means of number of the colonies ± standard deviations.
+: For the presence of the colonies
-: for absence of colonies
UC: uncountable
Table 5 Viability of microorganisms after 6 h exposure of polyphenol-rich fractions from Sida alba L
Microorganisms Time-kill (h)
0h 1h 2h 3h 4h 5h 6h
Shigella dysenteriae + (UC) + (UC) 23 ± 03 09 ± 02 04 ± 02 - -
Shigella boydii + (UC) + (UC) 25 ± 02 08 ± 02 05 ± 02 - -
Enterococcus faecalis + (UC) + (UC) 21 ± 01 08 ± 03 - - -
Proteus mirabilis + (UC) + (UC) 17 ± 0.00 05 ± 01 - - -
The results are the means of number of the colonies ± standard deviations.
+: For the presence of the colonies
-: for absence of colonies
UC: uncountable
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In short according our results, polyphenol-rich fractions
from Sida alba L. were found to possess promising anti-
microbial activities when applied alone or in combination
with conventional antimicrobial drugs to treat infectious
diseases due to multi-resistant bacterial strains.
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